Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Operating Expenses (2019 - 2025)

Silo Pharma's Operating Expenses history spans 7 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Operating Expenses rose 11.9% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $5.4 million, up 29.89%, while the annual FY2024 figure was $4.8 million, 21.68% up from the prior year.
  • Operating Expenses for Q3 2025 was $1.1 million at Silo Pharma, down from $1.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.8 million in Q4 2024 and bottomed at $453415.0 in Q2 2021.
  • The 5-year median for Operating Expenses is $965720.0 (2022), against an average of $985418.2.
  • The largest YoY upside for Operating Expenses was 475.11% in 2021 against a maximum downside of 54.55% in 2021.
  • A 5-year view of Operating Expenses shows it stood at $958982.0 in 2021, then skyrocketed by 74.51% to $1.7 million in 2022, then decreased by 29.47% to $1.2 million in 2023, then surged by 55.04% to $1.8 million in 2024, then plummeted by 37.22% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Operating Expenses are $1.1 million (Q3 2025), $1.3 million (Q2 2025), and $1.1 million (Q1 2025).